Related Experiment Videos
Serine phosphorylation of Stat6 negatively controls its DNA-binding function.
Nilesh R Maiti1, Pankaj Sharma, Phyllis C Harbor
1Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, OH 44195, USA.
Summary
Phosphorylation of Stat6 on serine residues in its transactivation domain inhibits DNA binding, negatively controlling interleukin-4 (IL-4)-responsive gene expression. This occurs without affecting Tyr(641) phosphorylation or nuclear translocation.
Area of Science:
- Molecular Biology
- Immunology
- Cell Signaling
Background:
- Interleukin-4 (IL-4) and IL-13 signaling are crucial for immune responses.
- Signal transducer and activator of transcription 6 (Stat6) mediates these signals.
- Stat6 activation involves phosphorylation, dimerization, and nuclear translocation.
Purpose of the Study:
- To investigate the role of Stat6 serine phosphorylation in IL-4-mediated gene transcription.
- To determine if serine phosphorylation affects Stat6 DNA-binding activity.
Main Methods:
- Phosphorylation site mapping of Stat6.
- Analysis of Stat6 DNA-binding activity in IL-4-stimulated cells.
- Assessment of Stat6 dimerization and nuclear translocation.
Main Results:
- Phosphorylation of multiple serine residues in the Stat6 transactivation domain (TAD) ablates DNA-binding activity.
- Serine phosphorylation does not impact Tyr(641) phosphorylation, dimerization, or nuclear translocation.
- These findings suggest a negative regulatory mechanism for IL-4-responsive gene expression.
Conclusions:
- Stat6 serine phosphorylation in the TAD is a critical regulator of IL-4 signaling.
- This phosphorylation event likely induces conformational changes, impairing DNA binding.
- This mechanism provides a novel insight into the control of inflammatory and immune responses mediated by IL-4 and IL-13.